AMT-116 in Patients with Solid Tumors

Clinical trial NCT06782334 · RECRUITING

Trial details

NCT number: NCT06782334
Sponsor: Multitude Therapeutics Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2024-05-07
Primary completion: 2026-06-30
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.